Pharming Non Current Assets Total from 2010 to 2025

PHAR Stock  USD 8.68  0.14  1.64%   
Pharming Group Non Current Assets Total yearly trend continues to be relatively stable with very little volatility. Non Current Assets Total are likely to grow to about 176.9 M this year. Non Current Assets Total is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. View All Fundamentals
 
Non Current Assets Total  
First Reported
2009-12-31
Previous Quarter
145.3 M
Current Value
143.3 M
Quarterly Volatility
59.8 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Pharming Group financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharming Group's main balance sheet or income statement drivers, such as Depreciation And Amortization of 19.2 M, Interest Expense of 6.4 M or Selling And Marketing Expenses of 7.4 M, as well as many indicators such as Price To Sales Ratio of 4.16, Dividend Yield of 0.0 or PTB Ratio of 3.92. Pharming financial statements analysis is a perfect complement when working with Pharming Group Valuation or Volatility modules.
  
Check out the analysis of Pharming Group Correlation against competitors.

Latest Pharming Group's Non Current Assets Total Growth Pattern

Below is the plot of the Non Current Assets Total of Pharming Group NV over the last few years. It is the total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets. Pharming Group's Non Current Assets Total historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pharming Group's overall financial position and show how it may be relating to other accounts over time.
Non Current Assets Total10 Years Trend
Slightly volatile
   Non Current Assets Total   
       Timeline  

Pharming Non Current Assets Total Regression Statistics

Arithmetic Mean88,497,774
Geometric Mean49,752,030
Coefficient Of Variation76.80
Mean Deviation61,270,403
Median113,393,960
Standard Deviation67,970,328
Sample Variance4620T
Range169.7M
R-Value0.94
Mean Square Error530.9T
R-Squared0.89
Slope13,489,322
Total Sum of Squares69299.5T

Pharming Non Current Assets Total History

2025176.9 M
2024168.5 M
2023146.5 M
2022148.3 M
2021147.7 M
2020155.5 M
2019136.3 M

About Pharming Group Financial Statements

Pharming Group shareholders use historical fundamental indicators, such as Non Current Assets Total, to determine how well the company is positioned to perform in the future. Although Pharming Group investors may analyze each financial statement separately, they are all interrelated. The changes in Pharming Group's assets and liabilities, for example, are also reflected in the revenues and expenses on on Pharming Group's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Non Current Assets Total168.5 M176.9 M

Additional Tools for Pharming Stock Analysis

When running Pharming Group's price analysis, check to measure Pharming Group's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharming Group is operating at the current time. Most of Pharming Group's value examination focuses on studying past and present price action to predict the probability of Pharming Group's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharming Group's price. Additionally, you may evaluate how the addition of Pharming Group to your portfolios can decrease your overall portfolio volatility.